Unlike αSMA(+) CAFs, INHBA(+) CAFs were enriched in HGSOC metastases and their proportion correlated with poor patient survival, suggesting that INHBA(+) CAFs might be active participants in cancer progression. The gene discussed is INHBA; the disease is cancer.